-
Signature
-
/s/ Vijay Iyer, Attorney-in-Fact
-
Stock symbol
-
BKNG
-
Transactions as of
-
Oct 15, 2025
-
Transactions value $
-
-$3,213,454
-
Form type
-
4
-
Date filed
-
10/16/2025, 04:30 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Fogel Glenn D |
CEO AND PRESIDENT, Director |
BOOKING HOLDINGS INC., 800 CONNECTICUT AVENUE, NORWALK |
/s/ Vijay Iyer, Attorney-in-Fact |
2025-10-16 |
0001516908 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BKNG |
Common Stock |
Sale |
-$81.1K |
-16 |
-0.07% |
$5,066.94 |
23.6K |
Oct 15, 2025 |
Direct |
F1, F2 |
| transaction |
BKNG |
Common Stock |
Sale |
-$5.07K |
-1 |
0% |
$5,068.25 |
23.6K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$5.07K |
-1 |
0% |
$5,070.38 |
23.6K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$218K |
-43 |
-0.18% |
$5,077.82 |
23.5K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$35.6K |
-7 |
-0.03% |
$5,079.58 |
23.5K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$30.5K |
-6 |
-0.03% |
$5,081.46 |
23.5K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$219K |
-43 |
-0.18% |
$5,100.22 |
23.5K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$30.6K |
-6 |
-0.03% |
$5,103.09 |
23.5K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$30.6K |
-6 |
-0.03% |
$5,104.43 |
23.5K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$220K |
-43 |
-0.18% |
$5,120.39 |
23.4K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$30.8K |
-6 |
-0.03% |
$5,126.32 |
23.4K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$221K |
-43 |
-0.18% |
$5,128.19 |
23.4K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$30.8K |
-6 |
-0.03% |
$5,130.93 |
23.4K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$247K |
-48 |
-0.21% |
$5,142.97 |
23.3K |
Oct 15, 2025 |
Direct |
F1, F3 |
| transaction |
BKNG |
Common Stock |
Sale |
-$30.9K |
-6 |
-0.03% |
$5,145.34 |
23.3K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$221K |
-43 |
-0.18% |
$5,150.68 |
23.3K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$283K |
-55 |
-0.24% |
$5,152.68 |
23.2K |
Oct 15, 2025 |
Direct |
F1, F4 |
| transaction |
BKNG |
Common Stock |
Sale |
-$30.9K |
-6 |
-0.03% |
$5,157.27 |
23.2K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$258K |
-50 |
-0.22% |
$5,159.47 |
23.2K |
Oct 15, 2025 |
Direct |
F1, F5 |
| transaction |
BKNG |
Common Stock |
Sale |
-$31K |
-6 |
-0.03% |
$5,160.98 |
23.2K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$253K |
-49 |
-0.21% |
$5,162.59 |
23.1K |
Oct 15, 2025 |
Direct |
F1, F6 |
| transaction |
BKNG |
Common Stock |
Sale |
-$222K |
-43 |
-0.19% |
$5,165.44 |
23.1K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$222K |
-43 |
-0.19% |
$5,167.53 |
23K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$31.2K |
-6 |
-0.03% |
$5,196.86 |
23K |
Oct 15, 2025 |
Direct |
F1 |
| transaction |
BKNG |
Common Stock |
Sale |
-$224K |
-43 |
-0.19% |
$5,211.74 |
23K |
Oct 15, 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: